Aphasia: early classification, evaluation of existing therapy, and novel therapeutics

Affiliations

Comment

Mark Willis et al. J Neurol. 2012 Nov.

. 2012 Nov;259(11):2510-2.

doi: 10.1007/s00415-012-6701-5.

No abstract available

Comment on

Quantitative classification of primary progressive aphasia at early and mild impairment stages.
Mesulam MM, Wieneke C, Thompson C, Rogalski E, Weintraub S. Mesulam MM, et al. Brain. 2012 May;135(Pt 5):1537-53. doi: 10.1093/brain/aws080. Epub 2012 Apr 23. Brain. 2012. PMID: 22525158 Free PMC article.
Galantamine administration in chronic post-stroke aphasia.
Hong JM, Shin DH, Lim TS, Lee JS, Huh K. Hong JM, et al. J Neurol Neurosurg Psychiatry. 2012 Jul;83(7):675-80. doi: 10.1136/jnnp-2012-302268. Epub 2012 May 17. J Neurol Neurosurg Psychiatry. 2012. PMID: 22595363 Clinical Trial.
Effectiveness of enhanced communication therapy in the first four months after stroke for aphasia and dysarthria: a randomised controlled trial.
Bowen A, Hesketh A, Patchick E, Young A, Davies L, Vail A, Long AF, Watkins C, Wilkinson M, Pearl G, Ralph MA, Tyrrell P. Bowen A, et al. BMJ. 2012 Jul 13;345:e4407. doi: 10.1136/bmj.e4407. BMJ. 2012. PMID: 22797843 Free PMC article. Clinical Trial.